Sign In
Buy JNJ
$239.08
+7.79 (+3.37%)
At Close: Jun 23, 2026
'No more tears': Author Gardiner Harris on J&J's controversies over the years
07:41am, Monday, 02'nd Jun 2025
Gardiner Harris, ‘No More Tears' author and former New York Times correspondent, joins 'Squawk Box' to discuss the controversies and challenges facing Johnson & Johnson over the years.
Johnson & Johnson: Relative Stability In A Wild 2025 Stock Market
10:07am, Friday, 30'th May 2025
Johnson & Johnson remains undervalued with strong profitability and reasonable valuation metrics, but growth prospects are modest and uncertain. Profitability is robust, with an A+ grade, high margins
J&J CEO Joaquin Duato on cancer treatments, M&A outlook and 'most favored nation' policy
08:04am, Friday, 30'th May 2025
CNBC's Angelica Peebles and Johnson & Johnson chairman and CEO Joaquin Duato join 'Squawk Box' to discuss the company's 5-year multiple myeloma treatment study, the company's cancer treatments, M&A ou
These 2 Dividend Stocks Have Grown Dividends For 50 Consecutive Years. Can That Streak Continue?
07:06am, Friday, 30'th May 2025
It may be too soon to rotate back into the risk trade as market volatility calms.
3 Elite High-Yield Dividend Stocks Down 8% to 27% That Have Hiked Their Payouts for More than 50 Years in a Row
06:21am, Thursday, 29'th May 2025
Some of the best dividend stocks in the world are on sale right now. Shares of Federal Realty Investment Trust (FRT -0.30%), Johnson & Johnson (JNJ -0.56%), and PepsiCo (PEP -0.56%) are currently down
Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results
04:43pm, Wednesday, 28'th May 2025
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Wednesday, July 16th to review second-quarter results. Joaq
Johnson & Johnson (JNJ) Presents at the Bernstein's 41st Annual Strategic Decisions Conference (Transcript)
02:31pm, Wednesday, 28'th May 2025
Johnson & Johnson (NYSE:JNJ ) Bernstein's 41st Annual Strategic Decisions Conference Call May 28, 2025 9:00 AM ET Company Participants Joaquin Duato - Chairman and Chief Executive Officer Joseph Wolk
Give Your Portfolio A Little Stability And Income Reliability During This Market Uncertainty
06:45am, Wednesday, 28'th May 2025
Market uncertainty and muted returns in 2025 make portfolio stability and income reliability crucial; dividend stocks are key for navigating volatility. General Mills offers a well-covered 4.4% yield,
Johnson & Johnson: Dividend King On Sale Yielding Over 3% And Undervalued
08:30am, Tuesday, 27'th May 2025
Despite legal headwinds and a declining share price, JNJ remains a financial powerhouse with strong profitability, a robust dividend, and aggressive buybacks. JNJ's 62-year streak of dividend growth,
1 Top Dividend Stock to Buy for a Lifetime of Passive Income
07:30am, Tuesday, 27'th May 2025
There are hundreds of dividend stocks on the market, but they don't all offer the same level of security. Some haven't increased their payouts in years.
Johnson & Johnson: Raising My Price Target Amid Stable EPS Growth
05:39am, Tuesday, 27'th May 2025
I maintain my buy rating on JNJ, citing attractive valuation, improved technicals, and a raised intrinsic value target of $184 per share. JNJ's recent earnings beat expectations, with strong Medicine
No Rolex For Me - I'm Buying Dividends That Pay For Life
07:30am, Monday, 26'th May 2025
I love luxury watches, but buying more to "earn" access to rarer models made me realize how easy it is to waste capital chasing ego-driven goals. Unlike watches, dividend growth stocks offer reliable
Generating Passive Income: 3 Top Dow Dividend Stocks to Buy for 2025 and Beyond
04:16am, Saturday, 24'th May 2025
The Dow Jones Industrial Average is an iconic stock market index. It tracks the performance of 30 of the country's most prominent publicly traded companies.
FDA Panel Reiterates the Cancer Risks of Talc
08:00am, Friday, 23'rd May 2025
WASHINGTON--(BUSINESS WIRE)--A panel of medical experts convened by the U.S. Food & Drug Administration urged the agency to study and adopt new standards to prohibit the use of talc in consumer produc
Johnson & Johnson (JNJ) Declines More Than Market: Some Information for Investors
06:46pm, Thursday, 22'nd May 2025
In the closing of the recent trading day, Johnson & Johnson (JNJ) stood at $152.51, denoting a -0.44% change from the preceding trading day.
